Showing 1 - 6 results of 6 for search 'Melinda Gooderham', query time: 0.24s
Refine Results
-
1
Targeting Interleukin 13 for the Treatment of Atopic Dermatitis by Yuliya Lytvyn, Melinda Gooderham
Published 2023-02-01
Article -
2
Clinical, patient and estimated cost benefits of proactive management versus reactive management with calcipotriol/betamethasone dipropionate foam for the treatment of plaque psori... by Rauno J. Harvima, Melinda Gooderham, Stephen Tyring, Henrik Thoning, Nanna Nyholm, Linda Stein Gold
Published 2022-05-01
Article -
3
Speed and Cumulative Responses According to Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Ixekizumab (Interleukin-17A Antagonist) versus Guselkumab... by Melinda Gooderham, Ronald Vender, Jeffrey Crowley, H. Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, Lawrence Green
Published 2024-02-01
Article -
4
-
5
Improvement in general touch avoidance in patients with moderate‐to‐severe genital psoriasis treated with ixekizumab during a 52‐week, randomized, phase 3 clinical trial (IXORA‐Q)... by Jennifer Soung, Jennifer C. Cather, Melinda Gooderham, Caitriona Ryan, Najwa Somani, Meghan Feely, Kyoungah See, Russel Burge, Mohamed Elrayes, Gaia Gallo, April W. Armstrong
Published 2023-06-01
Article -
6
Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry by Jonathan I. Silverberg, MD, PhD, MPH, Angel Cronin, MS, Eric A. Jones, PhD, MPH, Swapna S. Dave, MPH, MBBS, Robert R. McLean, DSc, MPH, Jeffrey Greenberg, MD, MPH, Bruce Strober, MD, PhD, Thomas Bieber, MD, PhD, MDRA, Melinda Gooderham, MSc, MD, Amy S. Paller, MD, Eric L. Simpson, MD
Published 2024-06-01
Article